JDOC vs TRUF

JDOCCJPMorgan Healthcare Leaders ETF

TRUFCVanEck Financials TruSector ETF

In short

JDOC Most healthcare ETFs just buy the sector list. JDOC is the stock-picker's version: about 60 names chosen by J.P. Morgan healthcare specialists hunting companies whose future growth the market underrates, with the whole globe in bounds.

TRUF Most active funds exist to beat a benchmark. TRUF is active so it can hug one: it holds US financials at true market weight, sidestepping the diversification caps that force many sector funds to shrink their largest names.

Stated mandate

JDOC Seeks long-term capital appreciation by investing primarily in healthcare companies that the adviser considers leaders, particularly where future growth is underappreciated by the market.

TRUF The Fund is an actively managed ETF seeking long-term capital appreciation through securities of financials-related companies or instruments providing exposure to such companies.

Why people hold it

• JDOC Concentrated by design: about 60 healthcare stocks rather than the full sector roster, so the managers' picks actually shape the portfolio.jpmorgan.com
• The mandate is global, so European and Asian drugmakers and device firms are as eligible as US-listed ones.jpmorgan.com
• Run by J.P. Morgan portfolio managers who specialize in healthcare inside its equity research groups, leaning on the firm's global bench of sector analysts.sec.govjpmorgan.com
• 0.65% a year for specialist active research sits right at the median fee for actively managed US equity ETFs, not a markup for the J.P. Morgan name.

• TRUF A 0.10% expense ratio, against a 0.65% median for actively managed US equity funds in its peer group.
• The hybrid build (individual stocks plus targeted ETFs) keeps a sector's biggest contributors at uncapped weight while staying inside fund diversification rules.businesswire.comvaneck.com
• Roughly 80 names, measured against the MarketVector Top US Financials Companies Index. The mandate is the sector itself, not a stock picker's shortlist.

Worth knowing

• JDOC A small fund that trades thinly since its 2023 launch, so spreads can run wider than on the giant healthcare index ETFs and execution matters more.
• One sector, roughly 60 names. Drug pricing rules, patent cliffs and trial outcomes land harder here than in a diversified fund.prnewswire.com
• Broad active core rivals like DFAC and AVLC charge under 0.2% for far wider portfolios. JDOC's fee reflects a narrow specialist mandate, not a core holding's price.

• TRUF VanEck says financials has not suffered the weighting distortions that hit tech and consumer discretionary, so the problem this structure solves is smaller here.vaneck.com
• Launched in 2026 and still a small fund, so spreads can run wider than in the sector's household-name ETFs. Limit orders are the usual tool for that.
• Owning other ETFs brings acquired fund fees, one of the items VanEck's expense arrangement does not cover, so total cost sits above the headline fee.vaneck.com

Full JDOC profile⁠

Full TRUF profile⁠